Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM.

Mathios D, Kim JE, Mangraviti A, Phallen J, Park CK, Jackson CM, Garzon-Muvdi T, Kim E, Theodros D, Polanczyk M, Martin AM, Suk I, Ye X, Tyler B, Bettegowda C, Brem H, Pardoll DM, Lim M.

Sci Transl Med. 2016 Dec 21;8(370):370ra180. doi: 10.1126/scitranslmed.aag2942.

2.

Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma.

Patel MA, Kim JE, Theodros D, Tam A, Velarde E, Kochel CM, Francica B, Nirschl TR, Ghasemzadeh A, Mathios D, Harris-Bookman S, Jackson CC, Jackson C, Ye X, Tran PT, Tyler B, Coric V, Selby M, Brem H, Drake CG, Pardoll DM, Lim M.

J Immunother Cancer. 2016 Nov 4;4:74. doi: 10.1186/s40425-016-0181-6. eCollection 2016.

3.

Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas.

Kim JE, Patel MA, Mangraviti A, Kim ES, Theodros D, Velarde E, Liu A, Sankey EW, Tam A, Xu H, Mathios D, Jackson CM, Harris-Bookman S, Garzon-Muvdi T, Sheu M, Martin AM, Tyler BM, Tran PT, Ye X, Olivi A, Taube JM, Burger PC, Drake CG, Brem H, Pardoll DM, Lim M.

Clin Cancer Res. 2017 Jan 1;23(1):124-136. doi: 10.1158/1078-0432.CCR-15-1535. Epub 2016 Jun 29.

4.

Non-virally engineered human adipose mesenchymal stem cells produce BMP4, target brain tumors, and extend survival.

Mangraviti A, Tzeng SY, Gullotti D, Kozielski KL, Kim JE, Seng M, Abbadi S, Schiapparelli P, Sarabia-Estrada R, Vescovi A, Brem H, Olivi A, Tyler B, Green JJ, Quinones-Hinojosa A.

Biomaterials. 2016 Sep;100:53-66. doi: 10.1016/j.biomaterials.2016.05.025. Epub 2016 May 21.

5.

Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma.

Patel MA, Kim JE, Theodros D, Tam A, Velarde E, Kochel CM, Francica B, Nirschl TR, Ghasemzadeh A, Mathios D, Harris-Bookman S, Jackson CC, Jackson C, Ye X, Tran PT, Tyler B, Coric V, Selby M, Brem H, Drake CG, Pardoll DM, Lim M.

J Immunother Cancer. 2016 May 17;4:28. doi: 10.1186/s40425-016-0132-2. eCollection 2016. Erratum in: J Immunother Cancer. 2016 Nov 4;4:74.

6.

Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium.

Kim ES, Kim JE, Patel MA, Mangraviti A, Ruzevick J, Lim M.

J Immunol Res. 2016;2016:4683607. doi: 10.1155/2016/4683607. Epub 2016 Jan 4. Review.

7.

Far-lateral transcondylar approach for microsurgical trapping of an anterior inferior cerebellar artery aneurysm.

Caplan JM, Jusue-Torres I, Kim JE, Luksik A, Liauw J, Gottschalk A, Tamargo RJ.

Neurosurg Focus. 2015 Jul;39 Video Suppl 1:V6. doi: 10.3171/2015.7.FocusVid.14581.

PMID:
26132623
8.

A multicenter study of 30 days complications after deceased donor liver transplantation in the model for end-stage liver disease score era.

Parikh A, Washburn KW, Matsuoka L, Pandit U, Kim JE, Almeda J, Mora-Esteves C, Halff G, Genyk Y, Holland B, Wilson DJ, Sher L, Koneru B.

Liver Transpl. 2015 Sep;21(9):1160-8. doi: 10.1002/lt.24181.

9.

Technical note: Orbitozygomatic craniotomy using an ultrasonic osteotome for precise osteotomies.

Ruzevick J, Raza SM, Recinos PF, Chaichana K, Pradilla G, Kim JE, Olivi A, Weingart J, Evans J, Quinones-Hinojosa A, Lim M.

Clin Neurol Neurosurg. 2015 Jul;134:24-7. doi: 10.1016/j.clineuro.2015.04.005. Epub 2015 Apr 13.

10.

Soft-tissue reconstruction after total en bloc sacrectomy.

Kim JE, Pang J, Christensen JM, Coon D, Zadnik PL, Wolinsky JP, Gokaslan ZL, Bydon A, Sciubba DM, Witham T, Redett RJ, Sacks JM.

J Neurosurg Spine. 2015 Jun;22(6):571-81. doi: 10.3171/2014.10.SPINE14114. Epub 2015 Mar 27.

PMID:
25815806
11.

The role of checkpoints in the treatment of GBM.

Kim JE, Lim M.

J Neurooncol. 2015 Jul;123(3):413-23. doi: 10.1007/s11060-015-1747-8. Epub 2015 Mar 7.

12.

Neurocytoma of the spinal cord.

Kim JE, Lim M.

Neurosurg Clin N Am. 2015 Jan;26(1):109-15. doi: 10.1016/j.nec.2014.09.005. Review.

PMID:
25432190
13.

The future of glioblastoma therapy: synergism of standard of care and immunotherapy.

Patel MA, Kim JE, Ruzevick J, Li G, Lim M.

Cancers (Basel). 2014 Sep 29;6(4):1953-85. doi: 10.3390/cancers6041953. Review.

14.

Microsurgical obliteration of a thoracic spinal perimedullary arteriovenous fistula.

Caplan JM, Groves M, Jusue-Torres I, Kim JE, Liauw J, Bydon A, Tamargo RJ.

Neurosurg Focus. 2014 Sep;37 Suppl 2:Video 13. doi: 10.3171/2014.V3.FOCUS14376.

PMID:
25175574
15.

High incidence of morbidity following resection of metastatic pheochromocytoma in the spine.

Kaloostian PE, Zadnik PL, Kim JE, Groves ML, Wolinsky JP, Gokaslan ZL, Witham TF, Bydon A, Sciubba DM.

J Neurosurg Spine. 2014 Jun;20(6):726-33. doi: 10.3171/2014.3.SPINE13535. Epub 2014 Apr 11.

PMID:
24725182
16.

STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications.

Kim JE, Patel M, Ruzevick J, Jackson CM, Lim M.

Cancers (Basel). 2014 Feb 10;6(1):376-95. doi: 10.3390/cancers6010376.

17.

Immediate and follow-up results for 44 consecutive cases of small (<10 mm) internal carotid artery aneurysms treated with the pipeline embolization device.

Lin LM, Colby GP, Kim JE, Huang J, Tamargo RJ, Coon AL.

Surg Neurol Int. 2013 Sep 6;4:114. doi: 10.4103/2152-7806.117711. eCollection 2013.

18.

Intracranial hemorrhage after spine surgery.

Kaloostian PE, Kim JE, Bydon A, Sciubba DM, Wolinsky JP, Gokaslan ZL, Witham TF.

J Neurosurg Spine. 2013 Sep;19(3):370-80. doi: 10.3171/2013.6.SPINE12863. Epub 2013 Jul 12.

PMID:
23848351
19.

Clay-shoveler's fracture during indoor rock climbing.

Kaloostian PE, Kim JE, Calabresi PA, Bydon A, Witham T.

Orthopedics. 2013 Mar;36(3):e381-3. doi: 10.3928/01477447-20130222-31.

PMID:
23464962
20.

Breast reconstruction.

Kim JE, Broyles JM, Shridharani SM, Sacks JM.

Eplasty. 2013;13:ic22. Epub 2013 Jan 28. No abstract available.

Supplemental Content

Loading ...
Support Center